PubMed

Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes.

Ekberg K, Brismar T, Johansson BL, Jonsson B, Lindström P, Wahren J.

Diabetes. 2003 Feb;52(2):536-41.PMID: 12540632 [PubMed - indexed for MEDLINE]Related articlesFree article

C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy.

Ekberg K, Brismar T, Johansson BL, Lindström P, Juntti-Berggren L, Norrby A, Berne C, Arnqvist HJ, Bolinder J, Wahren J.

Diabetes Care. 2007 Jan;30(1):71-6.PMID: 17192336 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.

Reljanovic M, Reichel G, Rett K, Lobisch M, Schuette K, Möller W, Tritschler HJ, Mehnert H.

Free Radic Res. 1999 Sep;31(3):171-9.PMID: 10499773 [PubMed - indexed for MEDLINE]Related articles

Subclinical nerve dysfunction in children and adolescents with IDDM.

Hyllienmark L, Brismar T, Ludvigsson J.

Diabetologia. 1995 Jun;38(6):685-92.PMID: 7672490 [PubMed - indexed for MEDLINE]Related articles

Effects of one year of near-normoglycemia on peripheral nerve function in type 1 (insulin-dependent) diabetic patients.

Ziegler D, Wiefels K, Dannehl K, Gries FA.

Klin Wochenschr. 1988 May 2;66(9):388-96.PMID: 2839729 [PubMed - indexed for MEDLINE]Related articles

Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus.

Johansson BL, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T, Wahren J.

Diabet Med. 2000 Mar;17(3):181-9.PMID: 10784221 [PubMed - indexed for MEDLINE]Related articles

C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.

Sima AA, Zhang W, Sugimoto K, Henry D, Li Z, Wahren J, Grunberger G.

Diabetologia. 2001 Jul;44(7):889-97.PMID: 11508275 [PubMed - indexed for MEDLINE]Related articles

Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.

Brooks B, Delaney-Robinson C, Molyneaux L, Yue DK.

J Diabetes Complications. 2008 Mar-Apr;22(2):88-95.PMID: 18280438 [PubMed - indexed for MEDLINE]Related articles

Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy.

Bril V, Buchanan RA.

Diabetes Care. 2006 Jan;29(1):68-72.PMID: 16373898 [PubMed - indexed for MEDLINE]Related articlesFree article

Elevated von Willebrand factor antigen predicts deterioration in diabetic peripheral nerve function.

Plater ME, Ford I, Dent MT, Preston FE, Ward JD.

Diabetologia. 1996 Mar;39(3):336-43.PMID: 8721780 [PubMed - indexed for MEDLINE]Related articles

Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetes.

Ekberg K, Johansson BL.

Exp Diabetes Res. 2008;2008:457912. Review.PMID: 18350117 [PubMed - indexed for MEDLINE]Related articlesFree article

Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial.

Ratner RE, Dickey R, Fineman M, Maggs DG, Shen L, Strobel SA, Weyer C, Kolterman OG.

Diabet Med. 2004 Nov;21(11):1204-12.PMID: 15498087 [PubMed - indexed for MEDLINE]Related articles

A double blind placebo controlled trial of mixed gangliosides in diabetic peripheral and autonomic neuropathy.

Abraham RR, Abraham RM, Wynn V.

Adv Exp Med Biol. 1984;174:607-24.PMID: 6331138 [PubMed - indexed for MEDLINE]Related articles

Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy.

Jaspan JB, Herold K, Bartkus C.

Am J Med. 1985 Nov 15;79(5A):24-37.PMID: 3000176 [PubMed - indexed for MEDLINE]Related articles

The effect of gamma-linolenic acid on human diabetic peripheral neuropathy: a double-blind placebo-controlled trial.

Jamal GA, Carmichael H.

Diabet Med. 1990 May;7(4):319-23.PMID: 2159860 [PubMed - indexed for MEDLINE]Related articles

Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy.

Service FJ, Rizza RA, Daube JR, O'Brien PC, Dyck PJ.

Diabetologia. 1985 Oct;28(10):722-7.PMID: 3905469 [PubMed - indexed for MEDLINE]Related articles

Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function. The Tolrestat Study Group.

Santiago JV, Snksen PH, Boulton AJ, Macleod A, Beg M, Bochenek W, Graepel GJ, Gonen B.

J Diabetes Complications. 1993 Jul-Sep;7(3):170-8.PMID: 8343611 [PubMed - indexed for MEDLINE]Related articles

Optimal blood glucose control during 18 years preserves peripheral nerve function in patients with 30 years' duration of type 1 diabetes.

Larsen JR, Sjoholm H, Hanssen KF, Sandvik L, Berg TJ, Dahl-Jorgensen K.

Diabetes Care. 2003 Aug;26(8):2400-4.PMID: 12882869 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.

Vinik AI, Bril V, Kempler P, Litchy WJ, Tesfaye S, Price KL, Bastyr EJ 3rd; MBBQ Study Group.

Clin Ther. 2005 Aug;27(8):1164-80.PMID: 16199243 [PubMed - indexed for MEDLINE]Related articles

Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial.

Malik RA, Williamson S, Abbott C, Carrington AL, Iqbal J, Schady W, Boulton AJ.

Lancet. 1998 Dec 19-26;352(9145):1978-81.PMID: 9872248 [PubMed - indexed for MEDLINE]Related articles